
Bioorganic and Medicinal Chemistry Letters p. 2467 - 2472 (1998)
Update date:2022-08-05
Topics:
Nerenberg, Jennie B.
Erb, Jill M.
Thompson, Wayne J.
Lee, Hee-Yoon
Guare, James P.
Munson, Peter M.
Bergman, Jeffrey M.
Huff, Joel R.
Broten, Theodore P.
Chang, Raymond S. L.
Chen, Tsing B.
O'Malley, Stacey
Schorn, Terry W.
Scott, Ann L.
Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect
View MoreContact:13120882795;+86-21-34621078;+86-021-31122318
Address:Suite 2,No.2715 Longwu Road
Dongguan Albiya Energy Science and Technology Co.,Ltd
Contact:+86-769-22181286
Address:Huanan Industial Park, Dongguan,China
website:http://www.fwdchem.com
Contact:86-21-54450828
Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
jiangsu senxuan pharmaceutical and chemical co.,ltd
Contact:86-523-87982810
Address:hongqiao industrial zone,taixing,jiangsu china
Zhangjiagang Golden Reach Fine Chemical Co.,LTD.
Contact:+86-512-6585 6968
Address:Changfu Road, Dongsha Chemical Industry Park, Zhangjiagang City, Jiangsu Province, China
Doi:10.1021/jo01271a045
(1968)Doi:10.1039/DT9950001857
(1995)Doi:10.1248/cpb.15.1331
(1967)Doi:10.1039/j39670002700
(1967)Doi:10.1016/S0040-4039(00)72432-4
(1973)Doi:10.1016/0957-4166(95)00201-Y
(1995)